Search Results

SCOHIA PHARMA presents results from Phase I diabetic nephropathies trial

• Source: Datamonitor, June 23, 2017, 1pp

Record details

Clinical Trial: Efficacy and Safety of Telmisartan Compared With Losartan

• Source: Health Daily Digest [HT Digital] (India), May 28, 2024, 1pp

Record details

Clinical Trial: Efficacy and Safety of Telmisartan Compared With Losartan

• Source: US Fed News (USA), May 28, 2024, 1pp

Record details

Clinical Trial: Use of Wharton Jelly in Diabetic Nephropathy

• Source: US Fed News (USA), September 21, 2017, 1pp

Record details

Clinical Trial: Use of Wharton Jelly in Diabetic Nephropathy

• Source: Health Daily Digest [HT Digital] (India), December 26, 2019, 1pp

Record details

Clinical Trial: Use of Wharton Jelly in Diabetic Nephropathy

• Source: Health Daily Digest [HT Digital] (India), September 28, 2017, 1pp

Record details

Global Diabetes Drug Market & Pipeline Insight 2015

• Authors : By:IBTimes Staff Reporter

• Source: International Business Times (USA), April 6, 2015 Press Release, 5pp

Record details

Intellectual Property India Publishes Patent Application for 'Method For Preventing And Treating Diabetic Nephropathy' Filed by Talengen International

• Source: Indian eGov Newswire (India), December 7, 2018, 1pp

Record details

Taiwan Patent Office Releases Talengen Institute of Life Sciences's Patent Application for Method for Preventing and Treating Diabetic Nephropathy

• Source: Global IP News (India), March 18, 2019 Medical Patent News, 2pp

Record details

Talengen International Ltd Files Patent Application for Method for Preventing and Treating Diabetic Nephropathy

• Source: Indian Patents News (India), November 19, 2018 News, 2pp

Record details